Company news
Solasia Pharma KK news in 2022
Solasia Pharma KK's news releases, calls and decks from 2022, newest first.
Solasia Announces Launch of Darvias® in Japan
August 22, 2022
Solasia Pharma KK: Consolidated Financial Results for the First Six Months of the Fiscal Year Ending December 31, 2022 (under IFRS)
August 15, 2022
Solasia Pharma K K Announces Topline Data from Phase III AGENT Study of SP-05(arfolitixorin)
August 3, 2022
Solasia Pharma K K Announces Capital and Business Alliance with Nippon Kayaku Co., Ltd.
June 28, 2022
Solasia Pharma: DARVIAS® Injection 135mg (Generic Name: DARINAPARSIN /Development Code: SP-02) Approved in Japan
June 19, 2022
Solasia Pharma K K Announces Finance via Issuance of Unsecured Straight Bond and Warrant
February 14, 2022